glp 1 litigation GLP-1 Receptor Agonist Litigation: MDL 3094 GLP-1 Drugs Like Ozempic Face

Drops: non-injectable, may feel easier, but clinical evidence is more limited

GLP-1 isnt just an incretin - its a full gutbrainpancreas signaling axis

Drug Des Devel Ther 13:27452757 Martins FL, Bailey MA, Girardi ACC (2020) Endogenous activation of glucagon-like peptide-1 receptor contributes to blood pressure control: role of proximal tubule Na+/H+ exchanger isoform 3, renal angiotensin II, and insulin sensitivity

The headline finding: ALS is being reversed in animal models

Declaration of competing interest PS Declaration Statement: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

46 Native oxyntomodulin also significantly augments glucose-dependent insulin secretion acutely in subjects with obesity, with and without diabetes